Last 12 months
Inside the activity.
4 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Tax withholdingCommon Stock | 10,998 | $55.11 | $606,099.78 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 27 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 855,366 F10 · kind: The reporting person received 10,008 shares of common stock upon the net exercise of the 48,532 SARS. The reporting person forfeited 27,526 shares of common stock underlying the SARS in payment of the exercise price and 10,998 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Disposition to issuerCommon Stock | 27,526 | $55.11 | $1,516,957.86 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 26 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 866,364 F10 · kind: The reporting person received 10,008 shares of common stock upon the net exercise of the 48,532 SARS. The reporting person forfeited 27,526 shares of common stock underlying the SARS in payment of the exercise price and 10,998 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Exercise / conversionCommon Stock | 48,532 | $31.26 | $1,517,110.32 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 25 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 893,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · kind: The reporting person received 10,008 shares of common stock upon the net exercise of the 48,532 SARS. The reporting person forfeited 27,526 shares of common stock underlying the SARS in payment of the exercise price and 10,998 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Tax withholdingCommon Stock | 49,364 | $55.11 | $2,720,450.04 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 24 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 845,358 F9 · kind: The reporting person received 44,927 shares of common stock upon the net exercise of the 166,500 SARS. The reporting person forfeited 72,209 shares of common stock underlying the SARS in payment of the exercise price and 49,364 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Disposition to issuerCommon Stock | 72,209 | $55.11 | $3,979,437.99 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 23 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894,722 F9 · kind: The reporting person received 44,927 shares of common stock upon the net exercise of the 166,500 SARS. The reporting person forfeited 72,209 shares of common stock underlying the SARS in payment of the exercise price and 49,364 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Exercise / conversionCommon Stock | 166,500 | $23.90 | $3,979,350.00 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 22 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · kind: The reporting person received 44,927 shares of common stock upon the net exercise of the 166,500 SARS. The reporting person forfeited 72,209 shares of common stock underlying the SARS in payment of the exercise price and 49,364 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Tax withholdingCommon Stock | 92,723 | $55.11 | $5,109,964.53 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 21 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,431 F8 · kind: The reporting person received 84,393 shares of common stock upon the net exercise of the 244,698 SARS. The reporting person forfeited 67,582 shares of common stock underlying the SARS in payment of the exercise price and 92,723 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Disposition to issuerCommon Stock | 67,582 | $55.11 | $3,724,444.02 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 20 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 893,154 F8 · kind: The reporting person received 84,393 shares of common stock upon the net exercise of the 244,698 SARS. The reporting person forfeited 67,582 shares of common stock underlying the SARS in payment of the exercise price and 92,723 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Exercise / conversionCommon Stock | 244,698 | $15.22 | $3,724,303.56 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 19 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 960,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · kind: The reporting person received 84,393 shares of common stock upon the net exercise of the 244,698 SARS. The reporting person forfeited 67,582 shares of common stock underlying the SARS in payment of the exercise price and 92,723 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Tax withholdingCommon Stock | 39,804 | $55.11 | $2,193,598.44 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 18 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,038 F7 · kind: The reporting person received 36,226 shares of common stock upon the net exercise of the 166,804 SARS. The reporting person forfeited 90,774 shares of common stock underlying the SARS in payment of the exercise price and 39,804 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Disposition to issuerCommon Stock | 90,774 | $55.11 | $5,002,555.14 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 17 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 755,842 F7 · kind: The reporting person received 36,226 shares of common stock upon the net exercise of the 166,804 SARS. The reporting person forfeited 90,774 shares of common stock underlying the SARS in payment of the exercise price and 39,804 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Exercise / conversionCommon Stock | 166,804 | $29.99 | $5,002,451.96 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 16 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: The reporting person received 36,226 shares of common stock upon the net exercise of the 166,804 SARS. The reporting person forfeited 90,774 shares of common stock underlying the SARS in payment of the exercise price and 39,804 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Tax withholdingCommon Stock | 15,911 | $55.11 | $876,855.21 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 15 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 679,812 F6 · kind: The reporting person received 14,477 shares of common stock upon the net exercise of the 109,322 SARS. The reporting person forfeited 78,934 shares of common stock underlying the SARS in payment of the exercise price and 15,911 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Disposition to issuerCommon Stock | 78,934 | $55.11 | $4,350,052.74 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 14 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 695,723 F6 · kind: The reporting person received 14,477 shares of common stock upon the net exercise of the 109,322 SARS. The reporting person forfeited 78,934 shares of common stock underlying the SARS in payment of the exercise price and 15,911 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Exercise / conversionCommon Stock | 109,322 | $39.79 | $4,349,922.38 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 13 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 774,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: The reporting person received 14,477 shares of common stock upon the net exercise of the 109,322 SARS. The reporting person forfeited 78,934 shares of common stock underlying the SARS in payment of the exercise price and 15,911 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Tax withholdingCommon Stock | 73,606 | $55.11 | $4,056,426.66 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 12 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 665,335 F5 · kind: The reporting person received 66,996 shares of common stock upon the net exercise of the 236,852 SARS. The reporting person forfeited 96,250 shares of common stock underlying the SARS in payment of the exercise price and 73,606 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Disposition to issuerCommon Stock | 96,250 | $55.11 | $5,304,337.50 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 11 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738,941 F5 · kind: The reporting person received 66,996 shares of common stock upon the net exercise of the 236,852 SARS. The reporting person forfeited 96,250 shares of common stock underlying the SARS in payment of the exercise price and 73,606 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Exercise / conversionCommon Stock | 236,852 | $22.40 | $5,305,484.80 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 10 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 835,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The reporting person received 66,996 shares of common stock upon the net exercise of the 236,852 SARS. The reporting person forfeited 96,250 shares of common stock underlying the SARS in payment of the exercise price and 73,606 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Tax withholdingCommon Stock | 31,371 | $55.11 | $1,728,855.81 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 9 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598,339 F4 · kind: The reporting person received 28,553 shares of common stock upon the net exercise of the 116,018 SARS. The reporting person forfeited 56,094 shares of common stock underlying the SARS in payment of the exercise price and 31,371 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Disposition to issuerCommon Stock | 56,094 | $55.11 | $3,091,340.34 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 8 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 629,710 F4 · kind: The reporting person received 28,553 shares of common stock upon the net exercise of the 116,018 SARS. The reporting person forfeited 56,094 shares of common stock underlying the SARS in payment of the exercise price and 31,371 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Exercise / conversionCommon Stock | 116,018 | $26.65 | $3,091,879.70 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 7 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 685,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The reporting person received 28,553 shares of common stock upon the net exercise of the 116,018 SARS. The reporting person forfeited 56,094 shares of common stock underlying the SARS in payment of the exercise price and 31,371 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Tax withholdingCommon Stock | 44,019 | $55.11 | $2,425,887.09 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 6 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569,786 F3 · kind: The reporting person received 40,066 shares of common stock upon the net exercise of the 106,186 SARS. The reporting person forfeited 22,101 shares of common stock underlying the SARS in payment of the exercise price and 44,019 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Disposition to issuerCommon Stock | 22,101 | $55.11 | $1,217,986.11 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 5 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,805 F3 · kind: The reporting person received 40,066 shares of common stock upon the net exercise of the 106,186 SARS. The reporting person forfeited 22,101 shares of common stock underlying the SARS in payment of the exercise price and 44,019 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Exercise / conversionCommon Stock | 106,186 | $11.47 | $1,217,953.42 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 4 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The reporting person received 40,066 shares of common stock upon the net exercise of the 106,186 SARS. The reporting person forfeited 22,101 shares of common stock underlying the SARS in payment of the exercise price and 44,019 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Tax withholdingCommon Stock | 102,084 | $55.11 | $5,625,849.24 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 3 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529,720 F1 · kind: The reporting person received 92,918 shares of common stock upon the net exercise of the 240,000 Stock Appreciation Rights ("SARS"). The reporting person forfeited 44,998 shares of common stock underlying the SARS in payment of the exercise price and 102,084 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Disposition to issuerCommon Stock | 44,998 | $55.11 | $2,479,839.78 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 2 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631,804 F1 · kind: The reporting person received 92,918 shares of common stock upon the net exercise of the 240,000 Stock Appreciation Rights ("SARS"). The reporting person forfeited 44,998 shares of common stock underlying the SARS in payment of the exercise price and 102,084 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:36 UTC |
GOUDIS RICHARDChief Executive Officer
|
Exercise / conversionCommon Stock | 240,000 | $10.33 | $2,479,200.00 |
DisclosureSEC source: 0001209191-18-051483 · doc4.xml · nonDerivative · entry 1 GOUDIS RICHARD · CIK 0001311175 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 676,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received 92,918 shares of common stock upon the net exercise of the 240,000 Stock Appreciation Rights ("SARS"). The reporting person forfeited 44,998 shares of common stock underlying the SARS in payment of the exercise price and 102,084 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11. F2 · balance_after: On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 218,401 additional shares of common stock. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 106,034 | $0.00 Strike: $15.22 | $0.00 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · derivative · entry 14 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,034 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F6 · kind: The reporting person received 38,831 shares of common stock upon the net exercise of 106,034 SARS. The reporting person forfeited 29,016 shares of common stock underlying the SARS in payment of the exercise price and 38,187 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. F10 · derivative.underlying_shares: These SARS were previously reported as covering 53,017 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 37,528 | $0.00 Strike: $29.99 | $0.00 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · derivative · entry 13 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,528 shares Expires 2024-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F5 · kind: The reporting person received 8,719 shares of common stock upon the net exercise of 37,528 SARS. The reporting person forfeited 20,235 shares of common stock underlying the SARS in payment of the exercise price and 8,574 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. F9 · derivative.underlying_shares: These SARS were previously reported as covering 18,764 shares at an exercise price of $59.98 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 63,934 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · derivative · entry 12 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 63,934 shares Expires 2022-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F4 · kind: The reporting person received 19,255 shares of common stock upon the net exercise of 63,934 stock appreciation rights ("SARS"). The reporting person forfeited 25,743 shares of common stock underlying the SARS in payment of the exercise price and 18,936 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. F8 · derivative.underlying_shares: These SARS were previously reported as covering 31,967 shares at an exercise price of $44.79 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Tax withholdingCommon Stock | 38,187 | $55.62 | $2,123,960.94 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 10 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,745 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F6 · kind: The reporting person received 38,831 shares of common stock upon the net exercise of 106,034 SARS. The reporting person forfeited 29,016 shares of common stock underlying the SARS in payment of the exercise price and 38,187 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Disposition to issuerCommon Stock | 29,016 | $55.62 | $1,613,869.92 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 9 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,932 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F6 · kind: The reporting person received 38,831 shares of common stock upon the net exercise of 106,034 SARS. The reporting person forfeited 29,016 shares of common stock underlying the SARS in payment of the exercise price and 38,187 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionCommon Stock | 106,034 | $15.22 | $1,613,837.48 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 8 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F6 · kind: The reporting person received 38,831 shares of common stock upon the net exercise of 106,034 SARS. The reporting person forfeited 29,016 shares of common stock underlying the SARS in payment of the exercise price and 38,187 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Tax withholdingCommon Stock | 8,574 | $55.62 | $476,885.88 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 7 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,914 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F5 · kind: The reporting person received 8,719 shares of common stock upon the net exercise of 37,528 SARS. The reporting person forfeited 20,235 shares of common stock underlying the SARS in payment of the exercise price and 8,574 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Disposition to issuerCommon Stock | 20,235 | $55.62 | $1,125,470.70 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 6 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,488 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F5 · kind: The reporting person received 8,719 shares of common stock upon the net exercise of 37,528 SARS. The reporting person forfeited 20,235 shares of common stock underlying the SARS in payment of the exercise price and 8,574 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionCommon Stock | 37,528 | $29.99 | $1,125,464.72 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 5 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F5 · kind: The reporting person received 8,719 shares of common stock upon the net exercise of 37,528 SARS. The reporting person forfeited 20,235 shares of common stock underlying the SARS in payment of the exercise price and 8,574 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Tax withholdingCommon Stock | 18,936 | $55.62 | $1,053,220.32 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 4 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,195 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F4 · kind: The reporting person received 19,255 shares of common stock upon the net exercise of 63,934 stock appreciation rights ("SARS"). The reporting person forfeited 25,743 shares of common stock underlying the SARS in payment of the exercise price and 18,936 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Disposition to issuerCommon Stock | 25,743 | $55.62 | $1,431,825.66 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 3 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,131 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F4 · kind: The reporting person received 19,255 shares of common stock upon the net exercise of 63,934 stock appreciation rights ("SARS"). The reporting person forfeited 25,743 shares of common stock underlying the SARS in payment of the exercise price and 18,936 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
Exercise / conversionCommon Stock | 63,934 | $22.40 | $1,432,121.60 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 2 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F4 · kind: The reporting person received 19,255 shares of common stock upon the net exercise of 63,934 stock appreciation rights ("SARS"). The reporting person forfeited 25,743 shares of common stock underlying the SARS in payment of the exercise price and 18,936 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC |
PEZZULLO DAVIDChief Operating Officer
|
SaleCommon Stock | 33,070 | $55.64 | $1,840,014.80 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,940 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $55.06 to $56.04. The price reported reflects the weighted average sale price of $55.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 95,505 additional shares of common stock. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionStock Appreciation Rights · Derivative | 100,000 | $0.00 Strike: $23.90 | $0.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · derivative · entry 37 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2025-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · kind: The reporting person received 27,098 shares of common stock upon the net exercise of 100,000 SARS. The reporting person forfeited 42,764 shares of common stock underlying the SARS in payment of the exercise price and 30,138 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. F20 · kind: These SARS were previously reported as covering 50,000 shares at an exercise price of $47.80 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionStock Appreciation Rights · Derivative | 179,444 | $0.00 Strike: $15.22 | $0.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · derivative · entry 36 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 179,444 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · kind: The reporting person received 61,824 shares of common stock upon the net exercise of 179,444 SARS. The reporting person forfeited 48,869 shares of common stock underlying the SARS in payment of the exercise price and 68,751 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. F19 · kind: These SARS were previously reported as covering 89,722 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionStock Appreciation Rights · Derivative | 115,472 | $0.00 Strike: $29.99 | $0.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · derivative · entry 35 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 115,472 shares Expires 2024-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · kind: The reporting person received 25,333 shares of common stock upon the net exercise of 115,472 SARS. The reporting person forfeited 61,964 shares of common stock underlying the SARS in payment of the exercise price and 28,175 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. F18 · kind: These SARS were previously reported as covering 57,736 shares at an exercise price of $59.98 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionStock Appreciation Rights · Derivative | 90,798 | $0.00 Strike: $39.79 | $0.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · derivative · entry 34 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,798 shares Expires 2023-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: The reporting person received 12,382 shares of common stock upon the net exercise of 90,798 SARS. The reporting person forfeited 64,643 shares of common stock underlying the SARS in payment of the exercise price and 13,773 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. F17 · kind: These SARS were previously reported as covering 45,399 shares at an exercise price of $79.58 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionStock Appreciation Rights · Derivative | 158,950 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · derivative · entry 33 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 158,950 shares Expires 2022-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: The reporting person received 45,105 shares of common stock upon the net exercise of 158,950 SARS. The reporting person forfeited 63,691 shares of common stock underlying the SARS in payment of the exercise price and 50,154 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. F16 · kind: These SARS were previously reported as covering 79,475 shares at an exercise price of $44.79 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionStock Appreciation Rights · Derivative | 83,334 | $0.00 Strike: $26.65 | $0.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · derivative · entry 32 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 83,334 shares Expires 2021-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The reporting person received 20,646 shares of common stock upon the net exercise of 83,334 SARS. The reporting person forfeited 39,729 shares of common stock underlying the SARS in payment of the exercise price and 22,959 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. F15 · kind: These SARS were previously reported as covering 41,667 shares at an exercise price of $53.29 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionStock Appreciation Rights · Derivative | 60,932 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · derivative · entry 31 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,932 shares Expires 2020-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The reporting person received 22,930 shares of common stock upon the net exercise of 60,932 SARS. The reporting person forfeited 12,505 shares of common stock underlying the SARS in payment of the exercise price and 25,497 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. F14 · kind: These SARS were previously reported as covering 38,082 shares at an exercise price of $22.94 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionStock Appreciation Rights · Derivative | 160,000 | $0.00 Strike: $10.33 | $0.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · derivative · entry 30 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 160,000 shares Expires 2020-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The reporting person received 61,753 shares of common stock upon the net exercise of 160,000 SARS. The reporting person forfeited 29,580 shares of common stock underlying the SARS in payment of the exercise price and 68,667 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. F13 · kind: These SARS were previously reported as covering 80,000 shares at an exercise price of $20.665 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Exercise / conversionStock Appreciation Rights · Derivative | 100,000 | $0.00 Strike: $3.41 | $0.00 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · derivative · entry 29 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received 44,460 shares of common stock upon the net exercise of 100,000 stock appreciation rights ("SARS"). The reporting person forfeited 6,102 shares of common stock underlying the SARS in payment of the exercise price and 49,438 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. F12 · kind: These SARS were previously reported as covering 75,000 shares at an exercise price of $6.81 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:48 UTC |
DeSimone JohnCo-President
|
Tax withholdingCommon Stock | 30,138 | $55.89 | $1,684,412.82 |
DisclosureSEC source: 0001209191-18-051098 · doc4.xml · nonDerivative · entry 27 DeSimone John · CIK 0001463405 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,325 F10 · kind: The reporting person received 27,098 shares of common stock upon the net exercise of 100,000 SARS. The reporting person forfeited 42,764 shares of common stock underlying the SARS in payment of the exercise price and 30,138 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 13, 2018 of $55.89. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.